Full Text View
Tabular View
No Study Results Posted
Related Studies
Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study (MMAPPS)
This study is currently recruiting participants.
Verified November 2012 by Massachusetts General Hospital
Study NCT01522742   Information provided by Massachusetts General Hospital

First Received on December 29, 2011.   Last Updated on November 15, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Psoriasis
Additional conditions recognized in this trial
Atherosclerosis
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Skin Diseases
Skin Diseases, Papulosquamous
Vascular Diseases
Additional drug interventions recognized in this trial
TNFR-Fc fusion protein
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Gastrointestinal Agents
Immunologic Factors
Immunosuppressive Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Massachusetts General Hospital
Immunex Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services